earnings
confidence high
sentiment neutral
materiality 0.75
Ginkgo Q2 2025 revenue $50M, net loss $60M; achieves $250M cost savings goal ahead of schedule
Ginkgo Bioworks Holdings, Inc.
2025-Q2 EPS reported
-$2.77
revenue$97,922,000
- Total revenue $50M, down from $56M YoY; Cell Engineering rev up 8% to $39M; Biosecurity down to $10M.
- GAAP net loss $60M, improved from $217M YoY; Adjusted EBITDA -$28M, up from -$99M.
- Achieved $250M annualized cost reduction target three months ahead of schedule.
- Cash, equivalents, marketable securities $474M as of June 30, 2025.
- Reaffirmed FY2025 total revenue outlook $167-187M; Cell Engineering $117-137M; Biosecurity at least $40M.